Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
ATHA Athira
- 0.330
- +0.018+5.86%
Trading Mar 11 10:10 ET
12.90MMarket Cap-0.13P/E (TTM)
0.340High0.312Low28.07KVolume0.312Open0.312Pre Close9.14KTurnover0.10%Turnover RatioLossP/E (Static)39.04MShares3.67052wk High0.29P/B9.11MFloat Cap0.30152wk Low--Dividend TTM27.56MShs Float34.790Historical High--Div YieldTTM8.91%Amplitude0.301Historical Low0.325Avg Price1Lot Size
About Athira Company
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Company Profile
SymbolATHA
Company NameAthira
Listing DateSep 18, 2020
Issue Price17.00
Founded2011
CEODr. Mark J. Litton, PhD
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
Address18706 North Creek Parkway,Suite 104
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-620-8501
Websitehttp://www.athira.com
Company Executives
- Name
- Position
- Salary
- Dr. Mark J. Litton, PhD
- Director, President and Chief Executive Officer
- 2.26M
- Dr. Kevin Church, PhD
- Chief Scientific Officer
- --
- Robert Renninger
- Principal Financial Officer, Principal Accounting Officer and Vice President, Finance
- --
- John M. Fluke, Jr
- Independent Director
- 95.89K
- Dr. Michael A. Panzara, M.D.
- Independent Director
- 89.36K
- Joseph Edelman
- Independent Director
- 92.77K
- James A. Johnson
- Independent Director
- 106.87K
- Barbara Kosacz, J.D.
- Independent Director
- 102.39K
- Grant E. Pickering
- Independent Director
- 96.53K
- Mark Worthington
- General Counsel and Corporate Secretary
- --
- Kelly A. Romano
- Chairwoman of the Board
- 124.68K